日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients

更正:循环肿瘤DNA可优化局限期小细胞肺癌患者的巩固免疫疗法

Yang, Yin; Wu, Yuqi; Zhao, Jingjing; Zhang, Tao; Fei, Kailun; Zhao, Xiaotian; Deng, Lei; Zhang, Zhihui; Jiang, Ying; Wang, Jianyang; Liu, Wenyang; Wang, Xin; Wang, Song; Bao, Hua; Wu, Xue; Zhu, Minyi; Ou, Qiuxiang; Tang, Wei; Wang, Luhua; Wang, Zhijie; Bi, Nan

The role of thoracic radiotherapy in the setting of immunotherapy in polymetastatic esophageal squamous cell carcinoma: a multi-center cohort study

胸部放射治疗在多发性转移性食管鳞状细胞癌免疫治疗中的作用:一项多中心队列研究

Liu, Qi; Chen, Junqiang; Shen, Wenbin; Ye, Jinjun; Luo, Honglei; Zhang, Xizhi; Liu, Wenyang; Xu, Yujin; Zhang, Yingying; Liu, Anwen; Li, Xiaopeng; Ge, Hong; Wang, Qifeng; Luo, Hui; Zhao, Lina; Xie, Conghua; Lin, Qin; Xie, Congying; Wang, Luhua; Zhao, Kuaile

Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients

循环肿瘤DNA可优化局限期小细胞肺癌患者的巩固免疫疗法

Yang, Yin; Wu, Yuqi; Zhao, Jingjing; Zhang, Tao; Fei, Kailun; Zhao, Xiaotian; Deng, Lei; Zhang, Zhihui; Jiang, Ying; Wang, Jianyang; Liu, Wenyang; Wang, Xin; Wang, Song; Bao, Hua; Wu, Xue; Zhu, Minyi; Ou, Qiuxiang; Tang, Wei; Wang, Luhua; Wang, Zhijie; Bi, Nan

PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy

PACIFIC-5:一项针对不可切除的 III 期非小细胞肺癌患者,在同步或序贯放化疗后未出现疾病进展的情况下,进行度伐利尤单抗巩固治疗的 III 期临床试验

Wu, Yi-Long; Wu, Lin; Bi, Nan; Cil, Timucin; Ge, Hong; Zhu, Zhengfei; Wang, Chih-Liang; Zhang, Wei; Lv, Dongqing; Mingyan, E; Sun, Jianguo; Pan, Yi; Krzakowski, Maciej; Dikilitas, Mustafa; Sendur, Mehmet Ali Nahit; Kim, Young-Chul; Yang, Yanjiao; Mao, Rui; Zhang, Biao; Wang, Luhua

Current status and perspectives of esophageal cancer: a comprehensive review

食管癌的现状与展望:一项综合综述

Jiang, Wei; Zhang, Bo; Xu, Jiaqi; Xue, Liyan; Wang, Luhua

Long-term outcomes of postoperative radiotherapy for patients with pIIIA-N2 non-small-cell lung cancer after complete resection and adjuvant chemotherapy (PORT-C): a single-centre, randomized, phase 3 trial

完全切除和辅助化疗(PORT-C)后接受术后放疗的pIIIA-N2期非小细胞肺癌患者的长期疗效:一项单中心、随机、3期试验

Men, Yu; Bao, Yongxing; Bi, Nan; Zhou, Zongmei; Liang, Jun; Lv, Jima; Feng, Qinfu; Xiao, Zefen; Wang, Yan; Li, Junling; Wang, Jie; Gao, Shugeng; He, Jie; Hui, Zhouguang; Wang, Luhua

Impact of pneumonitis from radiotherapy combined with immune checkpoint inhibitors therapy on tumor progression and survival in patients with non-small cell lung cancer

放射治疗联合免疫检查点抑制剂治疗引起的肺炎对非小细胞肺癌患者肿瘤进展和生存的影响

Wang, Ziwei; Xu, Kunpeng; Sun, Han; Liang, Jun; Jiang, Wei; Wang, Luhua

Immunotherapy enhances the risk of tumor oxidative stress and metastasis in lung cancer with radiation pneumonitis

免疫疗法会增加伴有放射性肺炎的肺癌患者发生肿瘤氧化应激和转移的风险

Jiao, Ruidi; Xu, Wenbo; Xu, Kunpeng; Zhang, Mingxia; Liu, Weilong; Jiang, Wei; Wang, Luhua

Comparative analysis of immunochemotherapy with versus without radiation therapy for stage IVB esophageal squamous cell carcinoma confined to non-regional nodal metastases: a multicenter propensity score matching study

免疫化疗联合或不联合放疗治疗IVB期食管鳞状细胞癌(局限于非区域淋巴结转移)的疗效比较分析:一项多中心倾向评分匹配研究

Liu, Qi; Chen, Junqiang; Xu, Yuanji; Shen, Wenbin; Ye, Jinjun; Luo, Honglei; Zhang, Xizhi; Liu, Wenyang; Xu, Yujin; Zhang, Yingying; Liu, Anwen; Li, Xiaopeng; Ge, Hong; Wang, Qifeng; Luo, Hui; Zhao, Lina; Xie, Conghua; Lin, Qin; Xie, Congying; Xiong, Jianping; Chen, Weiwei; Wang, Luhua; Zhao, Kuaile

Development and validation of a machine learning-based prediction model for hepatorenal syndrome in liver cirrhosis patients using MIMIC-IV and eICU databases

利用MIMIC-IV和eICU数据库,开发和验证基于机器学习的肝硬化患者肝肾综合征预测模型

Yao, Fengwei; Luo, Ji; Zhou, Qian; Wang, Luhua; He, Zhijun